Clinical Trial

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

Study acronym: FIL_CTCL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 2, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is designed to describe the different approaches of systemic therapies for the treatment of Cutaneous T-cell Lymphoma in real world setting.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-09-05; most recent amendment 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2025-05-29
Trial Details
NCT Number NCT06588868
Lead Sponsor Fondazione Italiana Linfomi - ETS
Collaborators: Takeda
Conditions Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome
Enrollment 400 participants
Start Date 2025-02-27
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-12-02